Investor Opko Health, Inc.
13D/G Filings

This page shows a list of all the recent 13D/G filings made by Opko Health, Inc. . Schedule 13D is commonly referred to as a “beneficial ownership report.” The term "beneficial owner" is defined under SEC rules. It includes any person who directly or indirectly shares voting power or investment power (the power to sell the security).

When a person or group of persons acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities, they are required to file a Schedule 13D within ten days after the purchase. Click the link icon to see the full transaction history.

Add This Fund
to your dashboard

Date Form Target Prev
Shares		 Current
Shares		 Change
(Percent)		 Ownership
(Percent)		 Change
(Percent)
2025-04-02 13G ENTX / Entera Bio Ltd. 3,685,226
2024-11-20 13D/A WGS / GeneDx Holdings Corp. 1,746,674 1,370,841
2024-11-08 13D/A WGS / GeneDx Holdings Corp. 2,171,674 1,746,674
2024-09-18 13D/A WGS / GeneDx Holdings Corp. 2,502,146 2,171,674
2024-08-23 13D/A WGS / GeneDx Holdings Corp. 2,811,783 2,502,146
2024-08-12 13D/A WGS / GeneDx Holdings Corp. 3,123,403 2,811,783
2024-07-26 13D/A WGS / GeneDx Holdings Corp. 3,469,521 3,123,403
2024-07-05 13D/A WGS / GeneDx Holdings Corp. 3,469,521
2023-04-20 13D/A SMFR / Sema4 Holdings Corp - Class A 94,285,714 117,433,862
2023-02-03 13D/A SMFR / Sema4 Holdings Corp - Class A 80,000,000 94,285,714
2022-05-09 13D SMFR / Sema4 Holdings Corp - Class A 80,000,000
2020-11-19 13D/A COCP / Cocrystal Pharma, Inc. 3,685,681 3,695,056
2020-03-10 13D/A COCP / Cocrystal Pharma, Inc. 3,682,556 3,685,681
2019-11-22 13D/A COCP / Cocrystal Pharma, Inc. 3,666,931 3,682,556
2019-10-23 13D/A XBIO / Xenetic Biosciences, Inc. 267,138 267,138
2019-10-23 13D/A BCDA / BioCardia, Inc. 1,541,702 255,111
2019-10-02 13D/A NVCN / Neovasc Inc 3,385,753 338,575
2019-09-30 13D/A VBIV / VBI Vaccines Inc. 6,678,751 6,678,751
2019-07-29 13D XBIO / Xenetic Biosciences, Inc. 267,138
2019-06-12 13D VBIV / VBI Vaccines Inc. 6,678,751 6,678,751
2019-06-12 13D NVCN / Neovasc Inc 3,361,298 3,385,753
2019-06-12 13D NIMU / Non-Invasive Monitoring Systems, Inc. 54,690,325
2019-06-12 13D BCDA / BioCardia, Inc. 1,541,702
2019-05-09 13D COCP / Cocrystal Pharma, Inc. 2,659,685 3,666,931
2019-05-09 13G/A MBVX / MabVax Therapeutics Holdings, Inc. 488,131
2019-05-09 13D SRNE / Sorrento Therapeutics, Inc. 0
2019-05-09 13D ELOX / Eloxx Pharmaceuticals, Inc. 1,290,155
2019-05-09 13D PHIO / Phio Pharmaceuticals Corp. 66,857
2019-05-09 13D CDXC / ChromaDex Corporation 3,251,521
2019-03-13 13D/A VBIV / VBI Vaccines Inc. 6,023,014 6,678,751
2019-02-14 13G/A BCDA / BioCardia, Inc. 2,145,448 2,237,099
2019-02-14 13G/A NVCN / Neovasc Inc 5,063,841 3,361,298
2019-02-14 13G/A COCP / Cocrystal Pharma, Inc. 2,244,597 2,659,685
2018-02-14 13G/A NVCN / Neovasc Inc 4,000,000 5,063,841
2018-02-12 13G/A BCDA / BioCardia, Inc. 2,145,448
2018-02-12 13G/A PHIO / Phio Pharmaceuticals Corp. 446,360 66,857
2018-02-02 13G/A COCP / Cocrystal Pharma, Inc. 63,634,259 2,244,597
2017-12-27 13D/A ELOX / Eloxx Pharmaceuticals, Inc. 1,306,821
2017-12-27 13D/A ELOX / Eloxx Pharmaceuticals, Inc. 16,233,918 1,306,821
2017-11-14 13D/A ELOX / Eloxx Pharmaceuticals, Inc. 16,233,919 16,233,918
2017-11-01 13D/A VBIV / VBI Vaccines Inc. 6,023,014 6,678,752
2017-11-01 13D/A SVACF / SciVac Therapeutics Inc. 6,678,752
2017-09-20 13D/A OPK / OPKO Health, Inc. 191,466,286
2017-08-14 13D/A ELOX / Eloxx Pharmaceuticals, Inc. 16,107,097 16,233,919
2017-08-04 13D ELOX / Eloxx Pharmaceuticals, Inc. 16,107,097
2017-05-10 13G COCP / Cocrystal Pharma, Inc. 63,634,259
2017-03-31 13D VBIV / VBI Vaccines Inc. 6,023,014
2017-02-14 13G NVCN / Neovasc Inc 4,000,000
2017-02-14 13G/A ARNI / Arno Therapeutics, Inc. 2,261,903 2,261,903
2017-01-12 13G PHIO / Phio Pharmaceuticals Corp. 446,360
2017-01-12 13G PHIO / Phio Pharmaceuticals Corp. 224,138 446,360
2017-01-10 13D/A PHIO / Phio Pharmaceuticals Corp. 224,138
2017-01-10 13D/A PHIO / Phio Pharmaceuticals Corp. 224,138
2017-01-03 13G BCDA / BioCardia, Inc. 24,252,769
2017-01-03 13G BCDA / BioCardia, Inc.
2016-08-22 13G/A ARNI / Arno Therapeutics, Inc. 2,261,903
2014-01-07 13D/A SRNE / Sorrento Therapeutics, Inc. 0
2013-10-31 13G ARNI / Arno Therapeutics, Inc. 833,333
2013-03-22 13D PHIO / Phio Pharmaceuticals Corp. 67,241,380
2012-09-13 13D/A SRNE / Sorrento Therapeutics, Inc. 59,015,257